405 research outputs found
Discourse or dialogue? Habermas, the Bakhtin Circle, and the question of concrete utterances
This is the author's accepted manuscript. The final publication is available at Springer via the link below.This article argues that the Bakhtin Circle presents a more realistic theory of concrete dialogue than the theory of discourse elaborated by Habermas. The Bakhtin Circle places speech within the âconcrete whole utteranceâ and by this phrase they mean that the study of everyday language should be analyzed through the mediations of historical social systems such as capitalism. These mediations are also characterized by a determinate set of contradictionsâthe capital-labor contradiction in capitalism, for exampleâthat are reproduced in unique ways in more concrete forms of life (the state, education, religion, culture, and so on). Utterances always dialectically refract these processes and as such are internal concrete moments, or concrete social forms, of them. Moreover, new and unrepeatable dialogic events arise in these concrete social forms in order to overcome and understand the constant dialectical flux of social life. But this theory of dialogue is different from that expounded by Habermas, who tends to explore speech acts by reproducing a dualism between repeatable and universal âabstractâ discursive processes (commonly known as the ideal speech situation) and empirical uses of discourse. These critical points against Habermas are developed by focusing on six main areas: sentences and utterances; the lifeworld and background language; active versus passive understandings of language; validity claims; obligation and relevance in language; and dialectical universalism
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
Colorectal cancer is one of the main causes of cancer death worldwide, and novel biomarkers are
urgently needed for its early diagnosis and treatment. The utilization of metabolomics to identify
and quantify metabolites in body fluids may allow the detection of changes in their concentrations
that could serve as diagnostic markers for colorectal cancer and may also represent new therapeutic
targets. Metabolomics generates a pathophysiological âfingerprintâ that is unique to each individual.
The purpose of our study was to identify a differential metabolomic signature for metastatic colorectal
cancer. Serum samples from 60 healthy controls and 65 patients with metastatic colorectal cancer were
studied by liquid chromatography coupled to high-resolution mass spectrometry in an untargeted
metabolomic approach. Multivariate analysis revealed a separation between patients with metastatic
colorectal cancer and healthy controls, who significantly differed in serum concentrations of one
endocannabinoid, two glycerophospholipids, and two sphingolipids. These findings demonstrate that
metabolomics using liquid-chromatography coupled to high-resolution mass spectrometry offers a
potent diagnostic tool for metastatic colorectal cancer.This study was supported by a grant (n° 15CC056/DTS17/00081- ISCIII-FEDER) from the Fundación para la
InvestigaciĂłn Biosanitaria de AndalucĂa Oriental (FIBAO) and Roche Pharma S.L. Authors from the FundaciĂłn
MEDINA acknowledge the receipt of financial support from this public-private partnership of Merck Sharp &
Dohme de España S.A. with the University of Granada and Andalusian Regional Government (PIN-0474-2016)
A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in Italy
<p>Abstract</p> <p>Background</p> <p>In the last years a trend towards proximalization of colorectal carcinomas (CRC) has been reported. This study aims to evaluate the distribution of CRC and adenomatous polyps (ADP) to establish the presence of proximalization and to assess the potential predictors.</p> <p>Methods</p> <p>We retrieved histology reports of colonic specimens excised during colonoscopy, considering the exams performed between 1997 and 2006 at Cuneo Hospital, Italy. We compared the proportion of proximal lesions in the period 1997-2001 and in the period 2002-2006.</p> <p>Results</p> <p>Neoplastic lesions were detected in 3087 people. Proximal CRC moved from 25.9% (1997-2001) to 30.0% (2002-2006). Adjusting for sex and age, the difference was not significant (OR 1.23; 95% CI: 0,95-1,58). The proximal ADP proportion increased from 19.2% (1997-2001) to 26.0% (2002-2006) (OR: 1.43; 95% CI: 1.17-1.89). The corresponding figures for advanced proximal ADP were 6.6% and 9.5% (OR: 1.48; 95% CI: 1.02-2.17). Adjusting for gender, age, diagnostic period, symptoms and number of polyps the prevalence of proximal advanced ADP was increased among people â„ 70 years compared to those aged 55-69 years (OR 1.49; 95% CI: 1.032.16). The main predictor of proximal advanced neoplasia was the number of polyps detected per exam (> 1 polyp versus 1 polyp: considering all ADP: OR 2.16; 95% CI: 1.59-2.93; considering advanced ADP OR 1.63; 95% CI: 1.08-2.46). Adjusting for these factors, the difference between the two periods was no longer significant.</p> <p>Conclusions</p> <p>CRC do not proximalize while a trend towards a proximal shift in adenomas was observed among people â„ 70 years.</p
Classification of tumours
Tumours are classified according to the most differentiated cells with the exception of carcinomas where a few tumour cells show neuroendocrine differentiation. In this case these cells are regarded as redifferentiated tumour cells, and the tumour is not classified as neuroendocrine. However, it is now clear that normal neuroendocrine cells can divide, and that continuous stimulation of such cells results in tumour formation, which during time becomes increasingly malignant. To understand tumourigenesis, it is of utmost importance to recognize the cell of origin of the tumour since knowledge of the growth regulation of that cell may give information about development and thus possible prevention and prophylaxis of the tumour. It may also have implications for the treatment. The successful treatment of gastrointestinal stromal tumours by a tyrosine kinase inhibitor is an example of the importance of a correct cellular classification of a tumour. In the future tumours should not just be classified as for instance adenocarcinomas of an organ, but more precisely as a carcinoma originating from a certain cell type of that organ
- âŠ